Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Ocular Therapeut (OCUL)

Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Ocular Therapeutix: Q3 Earnings Snapshot AP - Thu Nov 14, 6:37AM CST

Ocular Therapeutix: Q3 Earnings Snapshot

OCUL : 8.52 (-2.96%)
Ocular Therapeutix™ Reports Third Quarter 2024 Results and Business Highlights GlobeNewswire - Thu Nov 14, 6:00AM CST

OCUL : 8.52 (-2.96%)
Ocular Therapeutix™ to Present at the Jefferies London Healthcare Conference and Ophthalmology Innovation Summit XIV GlobeNewswire - Wed Nov 13, 6:30AM CST

OCUL : 8.52 (-2.96%)
Ocular Therapeutix™ Appoints Namrata Saroj, OD, as Chief Business Officer GlobeNewswire - Tue Nov 12, 6:30AM CST

OCUL : 8.52 (-2.96%)
Ocular Therapeutix™ to Report Third Quarter 2024 Results on November 14, 2024 GlobeNewswire - Wed Nov 6, 6:30AM CST

OCUL : 8.52 (-2.96%)
Ocular Therapeutix™ Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLI™ in Wet AMD GlobeNewswire - Tue Oct 15, 6:30AM CDT

OCUL : 8.52 (-2.96%)
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Wed Oct 9, 3:05PM CDT

OCUL : 8.52 (-2.96%)
Ocular Therapeutix™ to Present at October Ophthalmology Meetings GlobeNewswire - Wed Oct 9, 6:30AM CDT

OCUL : 8.52 (-2.96%)
Ocular Therapeutix: Q2 Earnings Snapshot AP - Wed Aug 7, 6:38AM CDT

Ocular Therapeutix: Q2 Earnings Snapshot

OCUL : 8.52 (-2.96%)
Wall Street - shutterstock_156562427
3 Standout Stocks Under $10 With 86% Upside Potential or More Barchart - Wed Jul 24, 7:59AM CDT

As the chances for a September rate cut grow even stronger, these three penny stocks can emerge as substantial wealth creators.

AMZN : 198.38 (-2.22%)
AAPL : 228.52 (-0.21%)
NVDA : 146.67 (+0.53%)
OPAL : 3.70 (+0.82%)
OCUL : 8.52 (-2.96%)
NUVB : 2.70 (+4.65%)

Barchart Exclusives

2 Energy Dividend Stocks Yielding 6% to Pick Now Barchart - 14 minutes ago
These two have been favorites among income-focused investors due to their high and consistent distribution yield. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot